日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid Tumors.

Copanlisib 与 Nivolumab 联合治疗晚期实体瘤患者的安全性和有效性:一项 Ib 期研究

Carneiro Benedito A, Jotte Robert M, Gabrail Nashat Y, Wentzel Kristopher, Huang Funan, Chaturvedi Shalini, Weispfenning Anke, Hiemeyer Florian, Morcos Peter N, Mongay Soler Lidia, Childs Barrett H, Hansen Aaron R

A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML

ASCERTAIN试验的简明语言摘要:口服地西他滨联合西达唑啶与静脉注射地西他滨治疗MDS或CMML的疗效比较。

Garcia-Manero, Guillermo; McCloskey, James; Griffiths, Elizabeth A; Yee, Karen W L; Zeidan, Amer M; Al-Kali, Aref; Deeg, H Joachim; Sabloff, Mitchell; Keating, Mary-Margaret; Zhu, Nancy; Gabrail, Nashat Y; Fazal, Salman; Maly, Joseph; Odenike, Olatoyosi; DeZern, Amy E; O'Connell, Casey L; Roboz, Gail J; Busque, Lambert; Buckstein, Rena; Amin, Harshad; Leber, Brian; Shastri, Aditi; Oganesian, Aram; Keer, Harold N; Azab, Mohammad; Savona, Michael R

COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC

COMPANION-002 一项临床试验,比较研究性药物 CTX-009 联合紫杉醇与单用紫杉醇治疗二线晚期胆道癌的疗效。

Azad, Nilofer; Hu, Zishuo; Sahin, Ilyas; Iyer, Renuka; Aranha, Olivia; Hochster, Howard; Pathak, Priyadarshini; Paulson, Andrew Scott; Kalyan, Aparna; Liao, Chih-Yi; Tran, Nguyen; Kelley, Robin K; Heestand, Gregory; Cosgrove, David; El-Khoueiry, Anthony; Borad, Mitesh; Gabrail, Nashat Y; Majeed, Umair; Du, Lingling; Kamath, Suneel; Shumway, Nathan; Shroff, Rachna; Goyal, Lipika; Rosales, Minori; Javle, Milind

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

最新分析证实,拉丁美洲淋巴瘤患者感染 COVID-19 后预后持续不良:来自盖尔的 160 例患者队列研究

Floricel, Carla; Nipu, Nafiul; Biggs, Mikayla; Wentzel, Andrew; Canahuate, Guadalupe; Van Dijk, Lisanne; Mohamed, Abdallah; Fuller, C David; Marai, G Elisabeta; Gladstone, Douglas E; Howard, Christopher; Lyu, Mi-Ae; Mock, Jason; Adams, Darryl; Gibbs, Kevin; Li, Li; Huang, Meixian; Zeng, Ke; D'Alessio, Franco; Herlihy, James; Trevino, Sergio; Hari, Parameswaran; Sadeghi, Tara; Parmar, Simrit; Slutsky, Arthur; Mukherjee, Siddhartha; Garcia-Manero, Guillermo; McCloskey, James K; Griffiths, Elizabeth A; Yee, Karen; Zeidan, Amer M; Al-Kali, Aref; Deeg, H Joachim; Patel, Prapti; Sabloff, Mitchell; Keating, Mary-Margaret; Dao, Kim-Hien; Zhu, Nancy; Gabrail, Nashat Y; Fazal, Salman; Maly, Joseph; Odenike, Olatoyosi; Kantarjian, Hagop; DeZern, Amy E; O'Connell, Casey L; Roboz, Gail J; Busque, Lambert; Wells, Richard A; Amin, Harshad; Randhawa, Jasleen K; Leber, Brian; Hao, Yong; Keer, Harold N; Azab, Mohammad; Savona, Michael R; Martinez-Lopez, Joaquin; De La Cruz, Javier; Gil-Manso, Rodrigo; Cedillo, Angel; Alegre, Adrian; Llamas Sillero, Maria Pilar; Duarte, Rafael F; Jiménez-Yuste, Víctor; Hernandez, jose Angel; Kwon, Mi; Sanchez Godoy, Pedro; Martinez-Barranco, Pilar; Colás Lahuerta, Blanca; Herrera Puente, Pilar; Benito, Lauren; Velasco, Alberto; Matilla, Arturo; Alaez, Concha; Martos, Rafael; Martínez-Chamorro, Carmen; Quiroz, Keina; del Campo, Juan F; De La Fuente, Adolfo; Herraez, Maria Regina; Pascual, Adriana; Gomez, Elvira; Perez De Oteyza, Jaime; Ruiz, Elena; Diez Martin, Jose Luis; Garcia-Suarez, Julio; Padron, Eric; Hebert, Donnie; Gore, Steven D; Gillis, Nancy; Komrokji, Rami S; Saber, Wael; Al Baghdadi, Tareq; Liu, Jane Jijun; Gorak, Edward J; Lee, Cecilia; Borchert, Christine; Wilson, Steffanie H; Thompson, Jason; Walker, Mary Ellen; DiFronzo, Nancy L; DeZern, Amy E; Sekeres, Mikkael A; Savona, Michael R; McCloskey, James K; Griffiths, Elizabeth A; Yee, Karen; Zeidan, Amer M; Al-Kali, Aref; Deeg, H Joachim; Patel, Prapti; Sabloff, Mitchell; Keating, Mary-Margaret; Dao, Kim-Hien; Zhu, Nancy; Gabrail, Nashat; Fazal, Salman; Maly, Joseph; Odenike, Olatoyosi; Kantarjian, Hagop; DeZern, Amy E; O'Connell, Casey L; Roboz, Gail J; Busque, Lambert; Wells, Richard A; Amin, Harshad; Randhawa, Jasleen K; Leber, Brian; Hao, Yong; Keer, Harold N; Azab, Mohammad; Garcia-Manero, Guillermo; Shah, Surbhi; Gulati, Shuchi; Li, Ang; Fu, Julie; Kumar, Vaibhav; Zon, Rebecca; Kulkarni, Amit; Shah, Pankil; Byeff, Peter D; Nguyen, Ryan; Nagaraj, Gayathri; Puc, Matthew; Hwang, Clara; McKay, Rana; French, Benjamin; Hennessy, Cassandra; Warner, Jeremy L; Connors, Jean M; Shah, Dimpy P; Rosovsky, Rachel P; Ramdial, Jeremy L; Saliba, Rima M; Alousi, Amin M; Rondon, Gabriela; Chen, Julianne; Ledesma, Celina; Shpall, Elizabeth J; Chemaly, Roy; Champlin, Richard E; Perini, Guilherme Fleury; Villela, Luis; Beltran, Brady E; Castro, Denisse; Otero, Victoria; Kalmus, Mariana; Fiad, Lorena; Peña, Camila; Idrobo, Henry; Candelaria, Myrna; Von Glasenapp, Alana; Perdomo, Ivan; Feres, Carolina; Prates, Maria Virginia; Paredes, Sally Rose; Perez-Jacobo, Fernando; Ramirez-Ibarguen, Ana Florencia; Gajardo, Claudia; Salinas, Macarena Alejandra Roa; Otañez, Melani; Valvert, Fabiola; Arcuri, Leonardo Javier; Montaño Figueroa, Efreen; Di Stefano, Marcos; Baena, Rosio; Choque, Juan Antonio; Abello, Virginia; Valladares, Ximena; Sanchez, Sofia; Nancy, Cristaldo; Zambrano, Daniela; Lasso, Juan Felipe; Noboa, Andrea; Rojas, Christine; Teixeira, Larissa LC; Ospina, Juan Alejandro; Torres Viera, Marialejandra Alejandra; Sotomayor, Eduardo; Martinez, Humberto; Castillo, Jorge J; Skarbnik, Alan; Malpica Castillo, Luis

Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial

Voxtalisib (XL765) 治疗复发或难治性非霍奇金淋巴瘤或慢性淋巴细胞白血病患者:一项开放标签的 II 期试验

Brown, Jennifer R; Hamadani, Mehdi; Hayslip, John; Janssens, Ann; Wagner-Johnston, Nina; Ottmann, Oliver; Arnason, Jon; Tilly, Hervé; Millenson, Michael; Offner, Fritz; Gabrail, Nashat Y; Ganguly, Siddhartha; Ailawadhi, Sikander; Kasar, Siddha; Kater, Arnon P; Doorduijn, Jeanette K; Gao, Lei; Lager, Joanne J; Wu, Bin; Egile, Coumaran; Kersten, Marie José

A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer

一项随机II期临床试验,研究肿瘤血管破坏剂CA4P(福斯布雷他布林氨丁三醇)联合卡铂、紫杉醇和贝伐单抗治疗晚期非鳞状非小细胞肺癌的疗效。

Garon, Edward B; Neidhart, Jeffrey D; Gabrail, Nashat Y; de Oliveira, Moacyr R; Balkissoon, Jai; Kabbinavar, Fairooz

An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

一项开放标签、单臂、II期(PX-171-004)研究,旨在评估单药卡非佐米治疗既往未接受过硼替佐米治疗的复发和/或难治性多发性骨髓瘤患者的疗效。

Vij, Ravi; Wang, Michael; Kaufman, Jonathan L; Lonial, Sagar; Jakubowiak, Andrzej J; Stewart, A Keith; Kukreti, Vishal; Jagannath, Sundar; McDonagh, Kevin T; Alsina, Melissa; Bahlis, Nizar J; Reu, Frederic J; Gabrail, Nashat Y; Belch, Andrew; Matous, Jeffrey V; Lee, Peter; Rosen, Peter; Sebag, Michael; Vesole, David H; Kunkel, Lori A; Wear, Sandra M; Wong, Alvin F; Orlowski, Robert Z; Siegel, David S